Form 4: NeuroMetrix CFO Thomas Higgins Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Thomas Higgins, CFO of NeuroMetrix, Inc., reports the acquisition of 5,625 restricted stock units on November 22, 2023, vesting quarterly over three years starting January 1, 2024.

Summary

  • On November 22, 2023, Thomas T. Higgins, CFO of NeuroMetrix, Inc. acquired 5,625 restricted stock units.
  • These units vest in equal quarterly installments over three years, beginning on January 1, 2024.
  • Effective November 21, 2023, NeuroMetrix implemented a 1-for-8 reverse stock split.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. The reverse stock split is a corporate action often undertaken to increase the stock price to meet exchange listing requirements or to make the stock more attractive to investors.

Stakeholder Impact

  • The reverse stock split could impact shareholders by reducing the number of shares they hold, while potentially increasing the stock price per share.

Key Dates

DateDescription
11/21/2023Effective date of 1-for-8 reverse stock split.
11/22/2023Date of grant of 5,625 restricted stock units to Thomas Higgins.
01/01/2024Start date for quarterly vesting of restricted stock units.
03/06/2024Date of signature for the Form 4 filing.

Keywords

NeuroMetrix, Thomas Higgins, restricted stock units, reverse stock split, Form 4, NURO, CFO, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.